Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis ☆
Titel:
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis ☆
Auteur:
Hoffman-Censits, J. Tsiatas, M. Chang, P.M.-H. Kim, M. Antonuzzo, L. Shin, S.J. Gakis, G. Blais, N. Kim, S.H. Smith, A. Arranz Arija, J.A. Su, Y.L. Zagouri, F. Maruzzo, M. Tournigand, C. Forget, F. Schneider, A. Tyroller, K. Jacob, N. Grivas, P. Valderrama, B.P.